> top > docs > PubMed:27342131 > spans > 319-721 > annotations

PubMed:27342131 / 319-721 JSONTXT

Annnotations TAB JSON ListView MergeView

sentences

Id Subject Object Predicate Lexical cue
TextSentencer_T3 0-402 Sentence denotes The goal of this review is to streamline 30 years of research and ask a set of important questions: in Type 1 diabetes which glycation products correlate best with 1) past mean glycemia 2) reversibility with improved glycemic control, 2) cross-sectional severity of retinopathy, nephropathy and neuropathy and 3) the future long-term risk of progression of micro- and subclinical macrovascular disease.
T3 0-402 Sentence denotes The goal of this review is to streamline 30 years of research and ask a set of important questions: in Type 1 diabetes which glycation products correlate best with 1) past mean glycemia 2) reversibility with improved glycemic control, 2) cross-sectional severity of retinopathy, nephropathy and neuropathy and 3) the future long-term risk of progression of micro- and subclinical macrovascular disease.

pubmed-enju-pas

Id Subject Object Predicate Lexical cue
EnjuParser_T51 0-3 DT denotes The
EnjuParser_T52 4-8 NN denotes goal
EnjuParser_T53 9-11 IN denotes of
EnjuParser_T54 12-16 DT denotes this
EnjuParser_T55 17-23 NN denotes review
EnjuParser_T56 24-26 VBZ denotes is
EnjuParser_T57 27-29 TO denotes to
EnjuParser_T58 30-40 VB denotes streamline
EnjuParser_T59 41-49 NNS denotes 30 years
EnjuParser_T60 50-52 IN denotes of
EnjuParser_T61 53-61 NN denotes research
EnjuParser_T62 62-65 CC denotes and
EnjuParser_T63 66-69 VB denotes ask
EnjuParser_T64 70-71 DT denotes a
EnjuParser_T65 72-75 NN denotes set
EnjuParser_T66 76-78 IN denotes of
EnjuParser_T67 79-88 JJ denotes important
EnjuParser_T68 89-98 NNS denotes questions
EnjuParser_T69 98-99 -COLON- denotes :
EnjuParser_T70 100-102 IN denotes in
EnjuParser_T71 103-107 NN denotes Type
EnjuParser_T72 108-109 CD denotes 1
EnjuParser_T73 110-118 NN denotes diabetes
EnjuParser_T74 119-124 WDT denotes which
EnjuParser_T75 125-134 NN denotes glycation
EnjuParser_T76 135-143 NNS denotes products
EnjuParser_T77 144-153 VBP denotes correlate
EnjuParser_T78 154-158 JJS denotes best
EnjuParser_T79 159-163 IN denotes with
EnjuParser_T80 164-165 CD denotes 1
EnjuParser_T81 165-166 -RRB- denotes )
EnjuParser_T82 167-171 IN denotes past
EnjuParser_T83 172-176 JJ denotes mean
EnjuParser_T84 177-185 NN denotes glycemia
EnjuParser_T85 186-187 CD denotes 2
EnjuParser_T86 187-188 -RRB- denotes )
EnjuParser_T87 189-202 NN denotes reversibility
EnjuParser_T88 203-207 IN denotes with
EnjuParser_T89 208-216 VBN denotes improved
EnjuParser_T90 217-225 JJ denotes glycemic
EnjuParser_T91 226-233 NN denotes control
EnjuParser_T92 233-234 -COMMA- denotes ,
EnjuParser_T93 235-236 CD denotes 2
EnjuParser_T94 236-237 -RRB- denotes )
EnjuParser_T95 238-253 JJ denotes cross-sectional
EnjuParser_T96 254-262 NN denotes severity
EnjuParser_T97 263-265 IN denotes of
EnjuParser_T98 266-277 NN denotes retinopathy
EnjuParser_T99 277-278 -COMMA- denotes ,
EnjuParser_T100 279-290 NN denotes nephropathy
EnjuParser_T101 291-294 CC denotes and
EnjuParser_T102 295-305 NN denotes neuropathy
EnjuParser_T103 306-309 CC denotes and
EnjuParser_T104 310-311 LS denotes 3
EnjuParser_T105 311-312 -RRB- denotes )
EnjuParser_T106 313-316 DT denotes the
EnjuParser_T107 317-323 JJ denotes future
EnjuParser_T108 324-333 JJ denotes long-term
EnjuParser_T109 334-338 NN denotes risk
EnjuParser_T110 339-341 IN denotes of
EnjuParser_T111 342-353 NN denotes progression
EnjuParser_T112 354-356 IN denotes of
EnjuParser_T113 357-363 NN denotes micro-
EnjuParser_T114 364-367 CC denotes and
EnjuParser_T115 368-379 JJ denotes subclinical
EnjuParser_T116 380-393 JJ denotes macrovascular
EnjuParser_T117 394-401 NN denotes disease
EnjuParser_R50 EnjuParser_T52 EnjuParser_T51 arg1Of goal,The
EnjuParser_R51 EnjuParser_T52 EnjuParser_T53 arg1Of goal,of
EnjuParser_R52 EnjuParser_T55 EnjuParser_T53 arg2Of review,of
EnjuParser_R53 EnjuParser_T55 EnjuParser_T54 arg1Of review,this
EnjuParser_R54 EnjuParser_T52 EnjuParser_T56 arg1Of goal,is
EnjuParser_R55 EnjuParser_T62 EnjuParser_T56 arg2Of and,is
EnjuParser_R56 EnjuParser_T62 EnjuParser_T57 arg1Of and,to
EnjuParser_R57 EnjuParser_T59 EnjuParser_T58 arg2Of 30 years,streamline
EnjuParser_R58 EnjuParser_T59 EnjuParser_T60 arg1Of 30 years,of
EnjuParser_R59 EnjuParser_T61 EnjuParser_T60 arg2Of research,of
EnjuParser_R60 EnjuParser_T58 EnjuParser_T62 arg1Of streamline,and
EnjuParser_R61 EnjuParser_T63 EnjuParser_T62 arg2Of ask,and
EnjuParser_R62 EnjuParser_T65 EnjuParser_T63 arg2Of set,ask
EnjuParser_R63 EnjuParser_T65 EnjuParser_T64 arg1Of set,a
EnjuParser_R64 EnjuParser_T65 EnjuParser_T66 arg1Of set,of
EnjuParser_R65 EnjuParser_T68 EnjuParser_T66 arg2Of questions,of
EnjuParser_R66 EnjuParser_T68 EnjuParser_T67 arg1Of questions,important
EnjuParser_R67 EnjuParser_T65 EnjuParser_T69 arg1Of set,:
EnjuParser_R68 EnjuParser_T74 EnjuParser_T69 arg2Of which,:
EnjuParser_R69 EnjuParser_T77 EnjuParser_T70 arg1Of correlate,in
EnjuParser_R70 EnjuParser_T73 EnjuParser_T70 arg2Of diabetes,in
EnjuParser_R71 EnjuParser_T73 EnjuParser_T71 arg1Of diabetes,Type
EnjuParser_R72 EnjuParser_T73 EnjuParser_T72 arg1Of diabetes,1
EnjuParser_R73 EnjuParser_T76 EnjuParser_T74 arg1Of products,which
EnjuParser_R74 EnjuParser_T76 EnjuParser_T75 arg1Of products,glycation
EnjuParser_R75 EnjuParser_T76 EnjuParser_T77 arg1Of products,correlate
EnjuParser_R76 EnjuParser_T78 EnjuParser_T77 arg2Of best,correlate
EnjuParser_R77 EnjuParser_T77 EnjuParser_T79 arg1Of correlate,with
EnjuParser_R78 EnjuParser_T103 EnjuParser_T79 arg2Of and,with
EnjuParser_R79 EnjuParser_T80 EnjuParser_T81 arg1Of 1,)
EnjuParser_R80 EnjuParser_T80 EnjuParser_T82 arg1Of 1,past
EnjuParser_R81 EnjuParser_T99 EnjuParser_T82 arg2Of ",",past
EnjuParser_R82 EnjuParser_T84 EnjuParser_T83 arg1Of glycemia,mean
EnjuParser_R83 EnjuParser_T84 EnjuParser_T85 arg1Of glycemia,2
EnjuParser_R84 EnjuParser_T84 EnjuParser_T86 arg1Of glycemia,)
EnjuParser_R85 EnjuParser_T84 EnjuParser_T87 arg1Of glycemia,reversibility
EnjuParser_R86 EnjuParser_T84 EnjuParser_T88 arg1Of glycemia,with
EnjuParser_R87 EnjuParser_T91 EnjuParser_T88 arg2Of control,with
EnjuParser_R88 EnjuParser_T91 EnjuParser_T89 arg2Of control,improved
EnjuParser_R89 EnjuParser_T91 EnjuParser_T90 arg1Of control,glycemic
EnjuParser_R90 EnjuParser_T91 EnjuParser_T92 arg1Of control,","
EnjuParser_R91 EnjuParser_T93 EnjuParser_T92 arg2Of 2,","
EnjuParser_R92 EnjuParser_T93 EnjuParser_T94 arg1Of 2,)
EnjuParser_R93 EnjuParser_T96 EnjuParser_T95 arg1Of severity,cross-sectional
EnjuParser_R94 EnjuParser_T93 EnjuParser_T96 arg1Of 2,severity
EnjuParser_R95 EnjuParser_T96 EnjuParser_T97 arg1Of severity,of
EnjuParser_R96 EnjuParser_T98 EnjuParser_T97 arg2Of retinopathy,of
EnjuParser_R97 EnjuParser_T84 EnjuParser_T99 arg1Of glycemia,","
EnjuParser_R98 EnjuParser_T101 EnjuParser_T99 arg2Of and,","
EnjuParser_R99 EnjuParser_T100 EnjuParser_T101 arg1Of nephropathy,and
EnjuParser_R100 EnjuParser_T102 EnjuParser_T101 arg2Of neuropathy,and
EnjuParser_R101 EnjuParser_T80 EnjuParser_T103 arg1Of 1,and
EnjuParser_R102 EnjuParser_T109 EnjuParser_T103 arg2Of risk,and
EnjuParser_R103 EnjuParser_T109 EnjuParser_T104 arg1Of risk,3
EnjuParser_R104 EnjuParser_T104 EnjuParser_T105 arg1Of 3,)
EnjuParser_R105 EnjuParser_T109 EnjuParser_T106 arg1Of risk,the
EnjuParser_R106 EnjuParser_T109 EnjuParser_T107 arg1Of risk,future
EnjuParser_R107 EnjuParser_T109 EnjuParser_T108 arg1Of risk,long-term
EnjuParser_R108 EnjuParser_T109 EnjuParser_T110 arg1Of risk,of
EnjuParser_R109 EnjuParser_T111 EnjuParser_T110 arg2Of progression,of
EnjuParser_R110 EnjuParser_T111 EnjuParser_T112 arg1Of progression,of
EnjuParser_R111 EnjuParser_T114 EnjuParser_T112 arg2Of and,of
EnjuParser_R112 EnjuParser_T113 EnjuParser_T114 arg1Of micro-,and
EnjuParser_R113 EnjuParser_T117 EnjuParser_T114 arg2Of disease,and
EnjuParser_R114 EnjuParser_T117 EnjuParser_T115 arg1Of disease,subclinical
EnjuParser_R115 EnjuParser_T117 EnjuParser_T116 arg1Of disease,macrovascular

mondo_disease

Id Subject Object Predicate Lexical cue mondo_id
T2 103-118 Disease denotes Type 1 diabetes http://purl.obolibrary.org/obo/MONDO_0005147
T3 266-277 Disease denotes retinopathy http://purl.obolibrary.org/obo/MONDO_0005283
T4 279-290 Disease denotes nephropathy http://purl.obolibrary.org/obo/MONDO_0005240
T5 295-305 Disease denotes neuropathy http://purl.obolibrary.org/obo/MONDO_0005244

HP-phenotype

Id Subject Object Predicate Lexical cue hp_id
T2 103-118 Phenotype denotes Type 1 diabetes HP:0100651
T3 266-277 Phenotype denotes retinopathy HP:0000488
T4 279-290 Phenotype denotes nephropathy HP:0000112
T5 295-305 Phenotype denotes neuropathy HP:0009830